SALBUTAMOL DEMOGEN NEBULES (Demogen Australia Pty Ltd trading as DEMOGEN Pharmaceuticals)
Product name
SALBUTAMOL DEMOGEN NEBULES
Date registered
Evaluation commenced
Decision date
Approval time
123 (255 working days)
Active ingredients
salbutamol sulfate
Registration type
New generic medicine
Indication
For the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.